John Sharman - Mar 25, 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC (UBI)

Role
Chief Executive Officer
Signature
/s/ John Sharman
Stock symbol
UBI
Transactions as of
Mar 25, 2024
Transactions value $
$272,933
Form type
4
Date filed
3/25/2024, 06:45 PM
Previous filing
Jan 3, 2023
Next filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Options Exercise $273K +1.36M +1705.83% $0.20* 1.44M Mar 25, 2024 Direct
holding UBI Common Stock 276K Mar 25, 2024 By Wife F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBI Stock Option (Right to Buy) Options Exercise $0 -1.36M -100% $0.00* 0 Mar 25, 2024 Common Stock 1.36M $0.20 Direct F2, F3
holding UBI Performance Rights 2.5M Mar 25, 2024 Common Stock 2.5M Direct F4
holding UBI Perforamnce Rights 1.25M Mar 25, 2024 Common Stock 1.25M Direct F5
holding UBI Stock Option (Right to Buy) 2.36M Mar 25, 2024 Common Stock 2.36M $0.25 Direct F2, F3
holding UBI Stock Option (Right to Buy) 1.36M Mar 25, 2024 Common Stock 1.36M $0.30 Direct F2, F3
holding UBI Stock Option (Right to Buy) 1M Mar 25, 2024 Common Stock 1M $0.30 By superannuation fund F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 The options are fully vested and became exercisable after September 24, 2020. The options expiring in March 2024 were exercised on March 25, 2024.
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.